Evidence map›Paper›PMID 40351467›Full record

ArticleFrontiers in medicine2025

Kaposi sarcoma in an HIV-infected patient with high CD4 count: a case report and literature review.

Kedir Negesso Tukeni, Merid Lemma Kebede, Elias Ababulgu Abadiko, Tamirat Godebo Woyimo, Abdo Kedir Abafogi, Amare Hailu Ashine, Esayas Kebede Gudina

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Kedir Negesso TukeniDepartment of Internal Medicine, Jimma University, Jimma, Ethiopia.
Merid Lemma KebedeDepartment of Clinical Radiology, Jimma University, Jimma, Ethiopia.
Elias Ababulgu AbadikoDepartment of Internal Medicine, Jimma University, Jimma, Ethiopia.
Tamirat Godebo WoyimoDepartment of Internal Medicine, Jimma University, Jimma, Ethiopia.
Abdo Kedir AbafogiDepartment of Pathology, Jimma University, Jimma, Ethiopia.
Amare Hailu AshineDepartment of Internal Medicine, Jimma University, Jimma, Ethiopia.
Esayas Kebede GudinaDepartment of Internal Medicine, Jimma University, Jimma, Ethiopia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Kaposi sarcoma is a tumor commonly associated with human herpesvirus 8 (HHV-8) infection and is more prevalent in individuals with immunosuppression, such as those with HIV/AIDS, organ transplant recipients, or other conditions causing immune dysfunction. It typically presents as purple patches or nodules commonly affecting the skin or mucous membrane of the gastrointestinal tract, and can spread to the lymph nodes and lungs. This case report describes an 18-year-old male with vertical HIV infection, managed on a regimen of dolutegravir/lamivudine/tenofovir (DTG/3TC/TDF), and with a recent CD4 count of 627cells/mm

Indexed as

antiretroviral therapyCD4 lymphocyte countEthiopiaHIVhuman herpesvirus 8 (HHV-8)Kaposi sarcomalow-level viremiaopportunistic infections

Identifiers

PMID40351467
PMCPMC12061674

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.